Merck (MRK) Cash from Investing Activities (2016 - 2025)
Merck (MRK) has disclosed Cash from Investing Activities for 17 consecutive years, with -$11.2 billion as the latest value for Q4 2025.
- On a quarterly basis, Cash from Investing Activities fell 675.69% to -$11.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$13.7 billion, a 77.67% decrease, with the full-year FY2025 number at -$13.7 billion, down 77.67% from a year prior.
- Cash from Investing Activities was -$11.2 billion for Q4 2025 at Merck, down from -$283.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $53.0 million in Q4 2023 to a low of -$12.0 billion in Q4 2021.
- A 5-year average of -$2.8 billion and a median of -$1.3 billion in 2022 define the central range for Cash from Investing Activities.
- Peak YoY movement for Cash from Investing Activities: soared 103.03% in 2023, then crashed 2824.53% in 2024.
- Merck's Cash from Investing Activities stood at -$12.0 billion in 2021, then surged by 85.49% to -$1.7 billion in 2022, then soared by 103.03% to $53.0 million in 2023, then plummeted by 2824.53% to -$1.4 billion in 2024, then crashed by 675.69% to -$11.2 billion in 2025.
- Per Business Quant, the three most recent readings for MRK's Cash from Investing Activities are -$11.2 billion (Q4 2025), -$283.0 million (Q3 2025), and -$770.0 million (Q2 2025).